$JHX

Skelly Jonathan sold $2.0M of JHX

Skelly Jonathan (Pres. James Hardie NA) sold 65,000 shares of James Hardie Industries plc (JHX) at an average of $30.46 ($30.45–$30.46, $1.98M total) across 2 trades on 2026-08-25.

Original reporting
SEC EDGAR · Skelly Jonathan
Published Aug 27, 2026, 11:14 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 11:42 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$JHX
Bearish
medium confidence
Mentioned
$JHX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$JHXBearishLow
01

Why it matters

Direct insider sell provides fresh data for traders assessing JHX.

02

Market read

New insider sale may influence short-term trading sentiment for JHX.

03

What to watch

Sale could be part of a pre-arranged liquidity plan unrelated to company fundamentals.

Relevance 6/10Novelty 7/10Timing: filed today

Background

Form 4 filing discloses insider transactions to the SEC.

Company-level read

Ticker impact

$JHXBearishMedium confidence
Context

Officer Skelly Jonathan sold 65,000 shares for $1.98M, reducing his stake to 309,906 shares.

Expected impact

Potential short-term pressure on JHX price.

Evidence & confidence

Officer-level insider sale of nearly $2M is material; market may interpret as a negative signal.

Market effects

Minimal impact on building materials sector.

Limited to investors tracking JHX.

Low

Counterpoint

Insider may be diversifying; sale does not necessarily indicate negative outlook.

Key entities

  • James Hardie Industries plc

    Building materials manufacturer listed on NYSE under ticker JHX.

  • Skelly Jonathan

    President of James Hardie North America.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$JHXHighAI 9/10

Fitch revises James Hardie outlook on European divestiture

Fitch affirmed James Hardie's 'BBB' rating and revised its outlook to Stable from Negative after the company agreed to sell its European business to Holcim for $980M. The deal, expected to close in 2027, includes the sale of Fermacell and the closure of its European fiber cement business. Fitch expects James Hardie's EBITDA leverage to decrease to 2.5x by FYE 2027, supported by debt paydown and sale proceeds. The European operations contributed 11.5% of revenue and 7.2% of EBITDA in fiscal 2026.

$JHXHighAI 9/10

James Hardie to sell Fermacell for €840m to Holcim

James Hardie will sell its European walling and flooring business, Fermacell, to Holcim for €840m. The company plans to close its European fibre cement business, focusing on North America. Proceeds will repay debt and fund a $250m share repurchase program. Holcim expects the deal to be earnings-accretive from 2027.

$JHXHighAI 9/10

James Hardie ditches Europe, selling out to Holcim in $1.38b deal

James Hardie Industries is selling its Fermacell business in Europe to Holcim for €840 million ($1.38 billion) and exiting the region. The company will focus on its North American operations. According to James Hardie, the deal marks the end of its nine-year ownership of Fermacell.